Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 23 | Unruch JoelGeneral Counsel/Corp Secretary | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $172K 610 sh | Jan 26, 2026 |
| 23 | Unruch JoelGeneral Counsel/Corp Secretary | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $60K 214 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 22 | Bachrodt AmySVP, Finance | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $228K 5,000 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner |  UWMCUWM Holdings CorpOpen-market sale · 10b5-1 plan | SELL | $3.64M 632.9K sh | Jan 26, 2026 traded Jan 26, 2026 |
| 21 | Urist MarshallEVP, Research & Investments |  RPRXRoyalty Pharma plcOpen-market sale · 10b5-1 plan | SELL | $805K 20.0K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 20 | Unruch JoelGeneral Counsel/Corp Secretary | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $18K 64 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 20 | Unruch JoelGeneral Counsel/Corp Secretary | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $39K 138 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $278K 1,300 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $548K 2,600 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $447K 2,083 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $742K 3,487 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $918K 4,330 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 18 | Huntsman CaroleChief Commercial Officer |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $167K 340 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 16 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Open-market sale · 10b5-1 plan | SELL | $3.70M 632.9K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 16 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Open-market sale · 10b5-1 plan | SELL | $3.71M 632.9K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 15 | Kroeker NathanCCO and Interim CFO |  EOSEEos Energy Enterprises, Inc.Open-market sale · 10b5-1 plan | SELL | $802K 50.0K sh | Jan 26, 2026 traded Jan 26, 2026 |
| 13 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $43K 200 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 12 | Cheng Chi FungDirector, Chief Technology Officer |  CRDOCredo Technology Group Holding LtdOpen-market sale · 10b5-1 plan | SELL | $543K 3,928 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 12 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $674K 5,024 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 12 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $843K 6,239 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 12 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $788K 5,744 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 12 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $686K 5,038 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Cohlhepp RyanDirector, President and COO |  BCAXBicara Therapeutics Inc.Open-market sale · 10b5-1 plan | SELL | $69K 3,828 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $376K 2,861 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $97K 700 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 |  Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $471K 3,603 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $98K 700 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $60K 427 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $186K 1,400 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $376K 2,862 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $471K 3,604 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $71K 500 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 8 | Kussell William ADirector |  FWRGFirst Watch Restaurant Group, Inc.Open-market sale · 10b5-1 plan | SELL | $105K 6,165 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 8 | Sagati Aghili NaseemGeneral Counsel |  ARESAres Management CorpOpen-market sale · 10b5-1 plan | SELL | $65K 400 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 8 | Sagati Aghili NaseemGeneral Counsel | ARESAres Management Corp Open-market sale · 10b5-1 plan | SELL | $202K 1,249 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 7 | Gilliam Joseph EPRESIDENT & COO |  GKOSGLAUKOS CorpOpen-market sale · 10b5-1 plan | SELL | $413K 3,194 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 7 | Gilliam Joseph EPRESIDENT & COO | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $303K 2,406 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 7 | Gilliam Joseph EPRESIDENT & COO | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $394K 3,100 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 6 | Remer Eric RichardDirector, Chief Executive Officer |  EVCMEverCommerce Inc.Open-market sale · 10b5-1 plan | SELL | $66K 5,230 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 6 | Hyep IvanChief Financial Officer | BCAXBicara Therapeutics Inc. Open-market sale · 10b5-1 plan | SELL | $34K 1,882 sh | Jan 26, 2026 traded Jan 22, 2026 |